Design and evaluation of a peptide-based immunotoxin for breast cancer therapeutics

Immunotoxins are chimeric proteins comprising a specific cellular targeting domain linked to a cytotoxic factor. Here we describe the design and use of a novel, peptide-based immunotoxin that can initiate selective cytotoxicity on ErbB2-positive cells. ErbB2 is a receptor tyrosine kinase that is ove...

Descripción completa

Detalles Bibliográficos
Autores principales: Weigel, Kelsey J., Shen, Luqun, Thomas, Clayton L., Alber, Daniel, Drapalik, Lauren, Schafer, Zachary T., Lee, Shaun W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382514/
https://www.ncbi.nlm.nih.gov/pubmed/25853036
http://dx.doi.org/10.1016/j.fob.2015.03.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382514/
https://www.ncbi.nlm.nih.gov/pubmed/25853036
http://dx.doi.org/10.1016/j.fob.2015.03.005

Ejemplares similares